SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-112887
Filing Date
2024-10-04
Accepted
2024-10-04 16:00:07
Documents
12
Period of Report
2024-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cue-20241002.htm   iXBRL 8-K 56501
2 EX-10.1 cue-ex10_1.htm EX-10.1 45483
  Complete submission text file 0000950170-24-112887.txt   245772

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20241002.xsd EX-101.SCH 44884
14 EXTRACTED XBRL INSTANCE DOCUMENT cue-20241002_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 241354844
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)